Breaking

Asian markets open: Nikkei falls, Samsung rises 3.5%; can Sensex find footing?
Global wheat outlook: harvests, exports, and tight stocks drive price revisions
European stocks hit 4-month high on US-EU trade deal; Stoxx 600 rises 0.8%
EU-US trade deal: 15% tariff, $750B energy purchase — but pharma, steel excluded
Bitget faces regulatory heat in Australia over unlicensed 125x crypto futures
Victoria Greene dubs Tesla stock a ‘dumpster fire’: find out more
Panama Canal ports deal faces uncertainty as CK Hutchison seeks new consortium composition
CAC 40 Index forecast ahead of Kering, Airbus, Hermes, Renault earnings

Business
Investing
Stocks
World
Search for:

Investing

Acceleration of RAD204 Phase 1 dose escalation trial

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Maiden Drill Program Commences at Oasis Uranium Project

RAD receives IND approval from US FDA for Betabart (RV-01)

GTI Energy

Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (128)
- Investing (557)
- Stocks (654)
- World (639)

Disclaimer: perfectdaytrading.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts

Copyright © 2025 perfectdaytrading.com | All Rights Reserved

Top

Business
Investing
Stocks
World

Type above and press Enter to search. Press Esc to cancel.